Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents to date across nine different geographies Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual... Read more

Reforest the Tropics and New England Biolabs®, Inc. enter into agreement to plant 100 hectares of forest to offset carbon emissions

Mystic, CT and Ipswich, MA (August 15, 2019): Reforest The Tropics (RTT), a 501(c)(3) non-profit organization based in Mystic, Connecticut and New England Biolabs, Inc. (NEB®), a global leader in the production of reagents for the life science industry, announce that they have entered into an agreement to plant 100 hectares (247 acres) of new tropical... Read more

IDT launches oPools™ Oligo Pools – the longest, highest fidelity, and ready-to-use custom oligo pools on the market

Aug 15, 2019 Long, high-yield oligos with industry-beating low error rate enable researchers to skip amplification steps and start projects immediately CORALVILLE, IA (August 15, 2019) – Continuing its mission to advance biological research worldwide, Integrated DNA Technologies (IDT) has launched oPools™ Oligo Pools – ready-to-use pools of high quality DNA oligonucleotides (oligos) up to 350 nucleotides in length. Thanks... Read more

Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications

Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable Process — — New Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK, NY, August 5, 2019 — Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and... Read more

IDT and Clear Labs ink multi-year supplier agreement to improve food safety through NGS-based testing technology

Jul 25, 2019 Clear Labs chooses IDT’s NGS oligo products for use in groundbreaking NGS-based food safety platform CORALVILLE, IA (July 25, 2019) – As part of its ongoing mission to break down the barriers in genomics research, Integrated DNA Technologies (IDT) is extending its network of collaborations into food quality and safety. Through a new multi-year supplier agreement,... Read more

Fluidigm to Automate RNA Sequencing Library Preparation Using Microfluidics Technology

Automated Nanoscale RNA Library Preparation for Next-Generation Sequencing to Deliver Significant Savings and Workflow Efficiency for the Molecular Laboratory SOUTH SAN FRANCISCO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced it will introduce an automated RNA sequencing (RNA-seq) library preparation... Read more

Introducing GridION Mk1

Mon 29th July 2019 GridION is a desktop device that allows simple scaling of MinION and Flongle Flow Cells. Users are able to run up to five flow cells simultaneously, enabling the generation of as much as 150Gb (assuming 30Gb per flow cell) of sequence data if using all five MinION flow cells at the same... Read more

QIAGEN reports results for second quarter of 2019; updates full-year 2019 outlook due to decision to restructure China NGS partnership

Venlo, the Netherlands, July 24, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results of operations for the second quarter of 2019, achieving the outlook set for net sales growth and adjusted earnings per share at constant exchange rates (CER). QIAGEN also announced that it intends to restructure the current format... Read more

Bruker Announces Date and Time of Second Quarter 2019 Earnings Release and Webcast

BILLERICA, Mass., July 23, 2019 /PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2019 financial results on Thursday, August 1, 2019, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends.  To listen to the... Read more